LINC01801

Across TCGA pan-cancer cohorts, LINC01801 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC01801 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01801 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01801 expression acts as an unfavorable survival marker, although some lineages such as KIRC and UVM show a favorable association.

KIRC, UVM, and HNSC are the cancer types where LINC01801 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.728	0.531	<.001	167	view →
UVM	OS	Median	All	0.824	0.354	<.001	120	view →
HNSC	DFS	Tertile	All	0.717	0.516	<.001	69	view →
BRCA	OS	Tertile	III,IV	0.911	0.759	.002	32	view →
UCS	OS	Quartile	II,III,IV	0.746	0.316	.007	28	view →
LAML	DFS	Quartile	All	0.639	0.372	.007	28	view →
ACC	DFS	Median	III,IV	0.217	0.587	.001	27	view →
LGG	OS	Tertile	All	0.935	0.805	<.001	25	view →
KIRP	DFS	Median	II,III,IV	0.681	0.361	.011	22	view →
THCA	OS	Median	III,IV	0.983	0.733	.002	21	view →
DLBC	DFS	Median	III,IV	0.525	1.000	.013	19	view →
PRAD	DFS	Median	All	0.932	0.840	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC01801–KIRC (DFS)

Open the KIRC breakdown →